11-08-2008, 08:33 PM
|
 |
Reader
|
� |
Join Date: Apr 2006
Location: Propecia, CA
Posts: 1,838
|
|
Green Tea May Prevent Colon Cancer
Quote:
Cancer Epidemiol Biomarkers Prev. 2008 Nov;17(11):3020-5.
Green tea extracts for the prevention of metachronous colorectal adenomas: a pilot study.
Shimizu M, Fukutomi Y, Ninomiya M, Nagura K, Kato T, Araki H, Suganuma M, Fujiki H, Moriwaki H.
Department of Medicine, Gifu University Graduate School of Medicine, 1-1 Yanagido, Gifu 501-1194, Japan. [email protected].
BACKGROUND: Experimental studies indicate the chemopreventive properties of green tea extract (GTE) on colorectal cancer. Epidemiologically, green tea consumption of >10 cups daily reduced colorectal cancer risk in Japanese.
Because colorectal adenomas are the precursors to most sporadic colorectal cancers, we conducted a randomized trial to determine the preventive effect of GTE supplements on metachronous colorectal adenomas by raising green tea consumption in the target population from an average of 6 cups (1.5 g GTE) daily to >/=10 cups equivalent (2.5 g GTE) by supplemental GTE tablets.
METHODS: We recruited 136 patients, removed their colorectal adenomas by endoscopic polypectomy, and 1 year later confirmed the clean colon (i.e., no polyp) at the second colonoscopy. The patients were then randomized into two groups while maintaining their lifestyle on green tea drinking: 71 patients supplemented with 1.5 g GTE per day for 12 months and 65 control patients without supplementation.
Follow-up colonoscopy was conducted 12 months later in 125 patients (65 in the control group and 60 in the GTE group).
RESULTS: The incidence of metachronous adenomas at the end-point colonoscopy was 31% (20 of 65) in the control group and 15% (9 of 60) in the GTE group (relative risk, 0.49; 95% confidence interval, 0.24-0.99; P < 0.05). The size of relapsed adenomas was also smaller in the GTE group than in the control group (P < 0.001). No serious adverse events occurred in the GTE group.
CONCLUSION: GTE is an effective supplement for the chemoprevention of metachronous colorectal adenomas. (Cancer Epidemiol Biomarkers Prev 2008;17(11):3020-5).
|
https://www.ncbi.nlm.nih.gov/pubmed/1...?dopt=Abstract
|
Linear Mode
